Switching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden

Por Flodmark, Carl-Erik, Lilja, Katarina, Woehling, Heike, Järvholm, Kajsa
Publicado em 2013

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

Por Schwarz, Hans-Peter, Walczak, Mieczysław, Birkholz-Walerzak, Dorota, Szalecki, Mieczyslaw, Nanu, Michaela, Woehling, Heike, Schuck, Ellen
Publicado no Adv Ther (2016)

Erratum to: Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System

Por Rashid, Nazia, Saenger, Paul, Wu, Yi-Lin, Woehling, Heike, Frankel, Matthew, Lifshitz, Fima, Muenzberg, Michael, Rapaport, Robert
Publicado no Biol Ther (2014)

Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System

Por Rashid, Nazia, Saenger, Paul, Wu, Yi-Lin, Woehling, Heike, Frankel, Matthew, Lifshitz, Fima, Muenzberg, Michael, Rapaport, Robert
Publicado no Biol Ther (2014)

GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes

Por von Richter, Oliver, Skerjanec, Andrej, Afonso, Miguel, Sanguino Heinrich, Sabine, Poetzl, Johann, Woehling, Heike, Velinova, Maria, Koch, Annelize, Kollins, Dmitrij, Macke, Lars, Wuerth, Guido
Publicado no Br J Clin Pharmacol (2016)

Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study

Por Lorenz, Hanns-Martin, Schmitt, Wilhelm H, Tesar, Vladimir, Müller-Ladner, Ulf, Tarner, Ingo, Hauser, Ingeborg A, Hiepe, Falk, Alexander, Tobias, Woehling, Heike, Nemoto, Kyuichi, Heinzel, Peter A
Publicado em 2011